| Financial Year |
March 31 2023 |
| Monetary Funds |
1,817,070,767.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,500,000.00 |
| Accounts Receivable |
1,959,460,845.14 |
| Advances to Suppliers |
118,934,057.38 |
| Other Receivables |
138,703,566.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
803,093.50 |
| Inventories |
477,818,279.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
109,207,275.16 |
| Total Current Assets |
5,751,242,734.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
629,095,290.32 |
| Investment Properties |
132,214,037.39 |
| Fixed Assetes |
14,662,564,396.55 |
| Under-construction Projects |
465,443,688.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
194,465,328.23 |
| R&D expenses |
-- |
| Goodwill |
46,220,396.93 |
| Long-Term Deferred and Prepaid Expenses |
23,072,744.24 |
| Deferred Income Tax Assets |
105,895,537.93 |
| Other Non-Current Assets |
465,905,572.95 |
| Sub-Total of Non-Current Assets |
16,892,840,917.59 |
| Total Assets |
22,644,083,651.63 |
| Short-Term Loans |
3,893,359,111.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
368,824,000.00 |
| Accounts Payable |
1,167,883,114.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
139,460,762.57 |
| Taxes Payable |
70,525,733.75 |
| Interest Payable |
-- |
| Dividend Payable |
4,354,282.12 |
| Other payables |
684,526,966.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,416,409,737.24 |
| Other Current Liabilities |
41,389,494.09 |
| Sub-Total of Current Liabilities |
8,874,348,719.25 |
| Long-term Loans |
5,427,699,786.43 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,062,744,557.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,050,293.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,438,999,219.94 |
| Total Liabilities |
16,313,347,939.19 |
| Paid-In Capital(Or Share Stock) |
1,151,415,017.00 |
| Capital Surplus |
3,897,088,297.72 |
| Surplus Reserve |
337,991,479.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
422,421,907.63 |
| Minority Stockholder's Interest |
504,068,683.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,826,667,028.54 |
| Owner's Equity（Stockholder's Equity） |
6,330,735,712.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,644,083,651.63 |
